Huahai pharmaceutical: the net profit in the first quarter is expected to decrease by 41% - 50% year-on-year
Huahai pharmaceutical announced that in the first quarter of 2022, the company is expected to realize a net profit attributable to the parent company of 127-150 million yuan, a year-on-year decrease of about 41% - 50%.
This text is a result of machine translation.
Related companies：
In-depth
Consumer Discretionary
Amazon Global Selling: A Decade of Growth in a Vast Market
Dec 17, 2024 05:43 PM
Briefing Oct 20, 2023 06:03 PM
· Technology
China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Financials
Indonesian Rupiah Plunges 1.2% Against USD, Outpacing Ringgit's Decline
Dec 19, 2024 04:59 PM
Consumer Staples
Lack of Trust in AI Tech Leads Singaporean Companies to Cut Investments
Dec 19, 2024 04:50 PM
Financials
Indonesia to Establish 7 to 9 New Economic Zones Over the Next Four Years to Boost Growth
Indonesia plans to establish 7 to 9 new economic zones over the next four years as part of its strategy to attract more investment and drive economic growth, according to Coordinating Minister for Economic Affairs, Airlangga Hartarto.
Dec 12, 2024 03:54 PM
Briefing Aug 26, 2021 06:31 PM
· Healthcare
Huahai pharmaceutical: the net profit in the first half of the year was 516 million yuan, a year-on-year decrease of 10.84%
See more
Read next
Insight
In-depth
Insight
In-depth
Consumer Discretionary
Amazon Global Selling: A Decade of Growth in a Vast Market
Dec 17, 2024 05:43 PM
Insight
In-depth
Consumer Staples · Analysis
Din Tai Fung and the Globalization of Chinese Cuisine
Dec 03, 2024 08:26 PM
Insight
In-depth
Communication · Analysis
Podcast Marketing, A Useful Tool for Companies Going Overseas
Dec 02, 2024 02:15 PM